LENZ Therapeutics, Inc.LENZNASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank100
3Y CAGR+43.3%
Studio
Year-over-Year Change

Price-to-sales ratio

3Y CAGR
+43.3%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.9x
Strong expansion
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
202524.15-
20240.00-
20230.00-100.0%
20228.21-
20210.00-
20200.00-
20190.00-